Clinical Trial Update: Study in Healthy Volunteers of the Safety and Metabolism of Different Doses of the Anti-HIV Drug TMC278LA. [Phase 1]

View source ↗

Summary

This Phase 1 study in healthy volunteers evaluated the safety and metabolism of different doses of the long-acting HIV drug TMC278LA. The trial status is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TMC278LA (rilpivirine long-acting formulation)

Snippet

Sponsor: St Stephens Aids Trust | Conditions: HIV Infection | Phase 1 | Status: COMPLETED